Dr Carol K Kasper and Shelly An Kipnis concluded in an article on Hepatitis and Clotting-Factor Concentrates that single donor products were preferable for older children and adults who had little exposure to blood products. Read more about Dr Carol K Kasper and Shelly An Kipnis concluded in an article on Hepatitis and Clotting-Factor Concentrates that single donor products were preferable for older children and adults who had little exposure to blood products.
Dr Peter Jones wrote in an article that "cryoprecipitate is now the product of choice in major surgery, allowing the potent but antigenic animal fractions and expensive human concentrate to be reserved for major complications, the emergency treatment of patients with FVIII inhibitors, or, in the case of concentrate, for prophylaxis." Read more about Dr Peter Jones wrote in an article that "cryoprecipitate is now the product of choice in major surgery, allowing the potent but antigenic animal fractions and expensive human concentrate to be reserved for major complications, the emergency treatment of patients with FVIII inhibitors, or, in the case of concentrate, for prophylaxis."
At an international forum reported in Vox Sanguinis in 1972, Dr Biggs and Dr Dormandy assessed that patients with haemophilia could be adequately maintained with the use of cryoprecipitate. Read more about At an international forum reported in Vox Sanguinis in 1972, Dr Biggs and Dr Dormandy assessed that patients with haemophilia could be adequately maintained with the use of cryoprecipitate.
Professor J. Garrott Allen of Stanford University Medical Centre concluded in a paper published in 1972 that the risk of serum hepatitis from transfusions derived from prison and Skid Row populations was at least ten times that from the use of volunteer donors. Read more about Professor J. Garrott Allen of Stanford University Medical Centre concluded in a paper published in 1972 that the risk of serum hepatitis from transfusions derived from prison and Skid Row populations was at least ten times that from the use of volunteer donors.
Grady et al "Risk of Posttransfusion Hepatitis in the United States: A Prospective Cooperative Study" reported on the National Transfusion Hepatitis Study in the US, that those cases of hepatitis with which Hepatitis B antigen was associated accounted for around 60 percent of the cases of post-transfusion hepatitis which had occurred. Read more about Grady et al "Risk of Posttransfusion Hepatitis in the United States: A Prospective Cooperative Study" reported on the National Transfusion Hepatitis Study in the US, that those cases of hepatitis with which Hepatitis B antigen was associated accounted for around 60 percent of the cases of post-transfusion hepatitis which had occurred.
In a journal article by Alter et al it was stated that the exclusion of commercial and HBAg positive blood donors had resulted in a marked reduction in post-transfusion hepatitis. Read more about In a journal article by Alter et al it was stated that the exclusion of commercial and HBAg positive blood donors had resulted in a marked reduction in post-transfusion hepatitis.
"The Gift Relationship" by Richard Titmuss was published, in which it was stated that the risk of catching hepatitis from blood taken from paid donors was higher than that of blood from unpaid donors. Read more about "The Gift Relationship" by Richard Titmuss was published, in which it was stated that the risk of catching hepatitis from blood taken from paid donors was higher than that of blood from unpaid donors.
In a journal article it was reported that the risk of causing hepatitis from blood taken from paid donors was markedly higher than that of blood from unpaid donors. Read more about In a journal article it was reported that the risk of causing hepatitis from blood taken from paid donors was markedly higher than that of blood from unpaid donors.
Dr Thomas visited Immuno factories in Vienna. Read more about Dr Thomas visited Immuno factories in Vienna.
Austrian Inspectors conducted an inspection of the manufacturing facilities regarding the Kryobulin licence application. Read more about Austrian Inspectors conducted an inspection of the manufacturing facilities regarding the Kryobulin licence application.